Szilagyi, MD 2 ; Harrell W. Chesson, PhD 3 ; Elizabeth R. Romero, MD 5 ; Lauri E. Markowitz, MD 1 View author affiliations. Vaccination against human papillomavirus HPV is routinely recommended at age 11 or 12 years.
Chemotherapy: oral side effects and dental interventions -a review of the literature
Human Papillomavirus (HPV) FAQs | Jo's Cervical Cancer Trust
The human papillomavirus HPV causes several cancers and genital warts among sexually active adolescent and young adult AYA males. A better understanding of the barriers AYA male patients, their parents, and their health care providers HCPs experience with respect to vaccination uptake is necessary for tailoring interventions for this population. Studies were included if they specified at least one barrier to vaccination uptake in AYA males. Studies were excluded if they did not focus on AYA males, their parents, or their HCP; were conducted outside the United States; or were published before A total of 23 studies were reviewed, and analysis found that these three groups i. Health care professionals working directly with AYA males and their parents should provide an open route of communication regarding these sensitive issues, and further educate families on the importance of HPV vaccines in reducing the incidence of certain cancers among men in later adulthood.
To synthesise lessons learnt and determinants of success from human papillomavirus HPV vaccine demonstration projects and national programmes in low- and middle-income countries LAMICs. Interviews were conducted with 56 key informants. A systematic literature review identified abstracts from five databases; after screening 61 full texts were included. Unpublished literature, including evaluation reports, was solicited from country representatives; documents were received. A data extraction tool and interview topic guide outlining key areas of inquiry were informed by World Health Organization guidelines for new vaccine introduction.
We conducted a systematic review of peer-reviewed studies on the knowledge and awareness of cervical cancer, HPV and HPV vaccine, and willingness and acceptability to vaccinate. There is an urgent need for more education to inform the public about HPV, HPV vaccine, and cervical cancer, particularly to key demographics, adolescents, parents and healthcare professionals , to leverage high levels of willingness and acceptability of HPV vaccine towards successful implementation of HPV vaccination programs. This is an open-access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.